Terms: = Colorectal cancer AND SPOP, TEF2, 8405, ENSG00000121067, O43791
16 results:
1. N6-methyladenosine-modified circSLCO1B3 promotes intrahepatic cholangiocarcinoma progression via regulating HOXC8 and PD-L1.
Li J; Xu X; Xu K; Zhou X; Wu K; Yao Y; Liu Z; Chen C; Wang L; Sun Z; Jiao D; Han X
J Exp Clin Cancer Res; 2024 Apr; 43(1):119. PubMed ID: 38641828
[TBL] [Abstract] [Full Text] [Related]
2. TMEM160 promotes tumor immune evasion and radiotherapy resistance via PD-L1 binding in colorectal cancer.
Dai X; Wu Z; Ruan R; Chen J; Huang C; Lei W; Yao Y; Li L; Tang X; Xiong J; Feng M; Deng J
Cell Commun Signal; 2024 Mar; 22(1):168. PubMed ID: 38454413
[TBL] [Abstract] [Full Text] [Related]
3. CSN6-spop-HMGCS1 Axis Promotes Hepatocellular Carcinoma Progression via YAP1 Activation.
Li K; Zhang J; Lyu H; Yang J; Wei W; Wang Y; Luo H; Zhang Y; Jiang X; Yi H; Wang M; Zhang C; Wu K; Xiao L; Wen W; Xu H; Li G; Wan Y; Yang F; Yang R; Fu X; Qin B; Zhou Z; Zhang H; Lee MH
Adv Sci (Weinh); 2024 Apr; 11(14):e2306827. PubMed ID: 38308184
[TBL] [Abstract] [Full Text] [Related]
4. Clinical significance of spop and APC gene alterations in colorectal cancer in Indian population.
Ali A; Nimisha ; Sharma AK; Mishra PK; Saluja SS
Mol Genet Genomics; 2023 Sep; 298(5):1087-1105. PubMed ID: 37289229
[TBL] [Abstract] [Full Text] [Related]
5. BET protein degradation triggers DR5-mediated immunogenic cell death to suppress colorectal cancer and potentiate immune checkpoint blockade.
Tong J; Tan X; Risnik D; Gao M; Song X; Ermine K; Shen L; Wang S; Yu J; Zhang L
Oncogene; 2021 Dec; 40(48):6566-6578. PubMed ID: 34615996
[TBL] [Abstract] [Full Text] [Related]
6. Aldehyde Dehydrogenase 2 Mediates Alcohol-Induced colorectal cancer Immune Escape through Stabilizing PD-L1 Expression.
Zhang H; Xia Y; Wang F; Luo M; Yang K; Liang S; An S; Wu S; Yang C; Chen D; Xu M; Cai M; To KKW; Fu L
Adv Sci (Weinh); 2021 May; 8(10):2003404. PubMed ID: 34026438
[TBL] [Abstract] [Full Text] [Related]
7. The GPER1/spop axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
[TBL] [Abstract] [Full Text] [Related]
8. ILF3 is a substrate of spop for regulating serine biosynthesis in colorectal cancer.
Li K; Wu JL; Qin B; Fan Z; Tang Q; Lu W; Zhang H; Xing F; Meng M; Zou S; Wei W; Chen H; Cai J; Wang H; Zhang H; Cai J; Fang L; Bian X; Chen C; Lan P; Ghesquière B; Fang L; Lee MH
Cell Res; 2020 Feb; 30(2):163-178. PubMed ID: 31772275
[TBL] [Abstract] [Full Text] [Related]
9. BET Inhibitors Potentiate Chemotherapy and Killing of
Tan X; Tong J; Wang YJ; Fletcher R; Schoen RE; Yu J; Shen L; Zhang L
Cancer Res; 2019 Mar; 79(6):1191-1203. PubMed ID: 30674532
[TBL] [Abstract] [Full Text] [Related]
10. miR-372 and miR-373 enhance the stemness of colorectal cancer cells by repressing differentiation signaling pathways.
Wang LQ; Yu P; Li B; Guo YH; Liang ZR; Zheng LL; Yang JH; Xu H; Liu S; Zheng LS; Zhou H; Qu LH
Mol Oncol; 2018 Nov; 12(11):1949-1964. PubMed ID: 30171794
[TBL] [Abstract] [Full Text] [Related]
11. Speckle-Type POZ Protein Down-Regulates Matrix Metalloproteinase 2 Expression via Sp1/PI3K/Akt Signaling Pathway in colorectal cancer.
Zhang S; Xiao J; Chai Y; Hong Z; Liu Z; Yuan R; Luo Z; Zhou X; Lucero-Prisno DE; Huang K
Dig Dis Sci; 2018 Feb; 63(2):395-402. PubMed ID: 29260353
[TBL] [Abstract] [Full Text] [Related]
12. Silencing speckle-type POZ protein by promoter hypermethylation decreases cell apoptosis through upregulating Hedgehog signaling pathway in colorectal cancer.
Zhi X; Tao J; Zhang L; Tao R; Ma L; Qin J
Cell Death Dis; 2016 Dec; 7(12):e2569. PubMed ID: 28032859
[TBL] [Abstract] [Full Text] [Related]
13. Relationship between spop mutation and breast cancer in Chinese population.
Khan MA; Zhu L; Tania M; Xiao XL; Fu JJ
Genet Mol Res; 2015 Oct; 14(4):12362-6. PubMed ID: 26505385
[TBL] [Abstract] [Full Text] [Related]
14. Properties and Clinical Relevance of Speckle-Type POZ Protein in Human colorectal cancer.
Xu J; Wang F; Jiang H; Jiang Y; Chen J; Qin J
J Gastrointest Surg; 2015 Aug; 19(8):1484-96. PubMed ID: 26022775
[TBL] [Abstract] [Full Text] [Related]
15. Mutational and expressional analyses of spop, a candidate tumor suppressor gene, in prostate, gastric and colorectal cancers.
Kim MS; Je EM; Oh JE; Yoo NJ; Lee SH
APMIS; 2013 Jul; 121(7):626-33. PubMed ID: 23216165
[TBL] [Abstract] [Full Text] [Related]
16. [Inhibitory effect and mechanism of (-)-epigallocatechin-3-gallate on HT29 and HCT-8 colorectal cancer cell lines and expression of HES1 and JAG1].
Zhang CX; Wang SM; Jin HY
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):636-9. PubMed ID: 21866461
[TBL] [Abstract] [Full Text] [Related]
